Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study for the PKU Carriers Trial: Evaluating the Impact of PKU Carrier Status on Cognition, Mental Health, Blood Pressure and L-phenylalanine Metabolism

NCT05958784 is registered in ClinicalTrials.gov with University of Guelph as lead sponsor.

NCT NCT05958784
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05958784 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study for the PKU Carriers Trial: Evaluating the Impact of PKU Carrier Status on Cognition, Mental Health, Blood Pressure and L-phenylalanine Metabolism
Lead sponsor
University of Guelph
Phase
Not applicable
Overall status
Completed
Start date
July 1, 2023
Completion date
December 1, 2023
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autosomal recessive disorder (genetic carriers of pku)